SCHOTT PHARMA AG& CO KGAA (1SXP.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1SXP - DE000A3ENQ51 - Common Stock
16.24 EUR
+16.24 (+Infinity%)
1SXP gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 22 industry peers in the Life Sciences Tools & Services industry. 1SXP has an excellent profitability rating, but there are some minor concerns on its financial health. 1SXP has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year 1SXP was profitable.
- In the past year 1SXP had a positive cash flow from operations.
- Of the past 5 years 1SXP 4 years were profitable.
- Of the past 5 years 1SXP 4 years had a positive operating cash flow.
1.2 Ratios
- 1SXP's Return On Assets of 9.61% is amongst the best of the industry. 1SXP outperforms 86.36% of its industry peers.
- With an excellent Return On Equity value of 17.02%, 1SXP belongs to the best of the industry, outperforming 86.36% of the companies in the same industry.
- 1SXP's Return On Invested Capital of 13.92% is amongst the best of the industry. 1SXP outperforms 86.36% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for 1SXP is significantly above the industry average of 9.34%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 17.02% | ||
| ROIC | 13.92% |
ROA(3y)11.06%
ROA(5y)11.96%
ROE(3y)19.55%
ROE(5y)21.48%
ROIC(3y)15.68%
ROIC(5y)17.03%
1.3 Margins
- Looking at the Profit Margin, with a value of 15.06%, 1SXP belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
- In the last couple of years the Profit Margin of 1SXP has remained more or less at the same level.
- The Operating Margin of 1SXP (19.46%) is better than 72.73% of its industry peers.
- 1SXP's Operating Margin has improved in the last couple of years.
- Looking at the Gross Margin, with a value of 33.73%, 1SXP is doing worse than 68.18% of the companies in the same industry.
- In the last couple of years the Gross Margin of 1SXP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.46% | ||
| PM (TTM) | 15.06% | ||
| GM | 33.73% |
OM growth 3Y3.98%
OM growth 5YN/A
PM growth 3Y0.22%
PM growth 5YN/A
GM growth 3Y-1.12%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- 1SXP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- There is no outstanding debt for 1SXP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- The Debt to FCF ratio of 1SXP is 1.72, which is an excellent value as it means it would take 1SXP, only 1.72 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 1.72, 1SXP belongs to the top of the industry, outperforming 95.45% of the companies in the same industry.
- A Debt/Equity ratio of 0.09 indicates that 1SXP is not too dependend on debt financing.
- With an excellent Debt to Equity ratio value of 0.09, 1SXP belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 1.72 | ||
| Altman-Z | N/A |
ROIC/WACC1.56
WACC8.91%
2.3 Liquidity
- 1SXP has a Current Ratio of 1.57. This is a normal value and indicates that 1SXP is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of 1SXP (1.57) is better than 72.73% of its industry peers.
- 1SXP has a Quick Ratio of 1.17. This is a normal value and indicates that 1SXP is financially healthy and should not expect problems in meeting its short term obligations.
- 1SXP's Quick ratio of 1.17 is fine compared to the rest of the industry. 1SXP outperforms 68.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.57 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
- 1SXP shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.02%.
EPS 1Y (TTM)-2.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.44%
3.2 Future
- The Earnings Per Share is expected to grow by 13.92% on average over the next years. This is quite good.
- The Revenue is expected to grow by 7.94% on average over the next years.
EPS Next Y18.66%
EPS Next 2Y16.45%
EPS Next 3Y15.84%
EPS Next 5Y13.92%
Revenue Next Year8.43%
Revenue Next 2Y9.34%
Revenue Next 3Y9.27%
Revenue Next 5Y7.94%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 16.74, which indicates a correct valuation of 1SXP.
- 86.36% of the companies in the same industry are more expensive than 1SXP, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 28.87, 1SXP is valued a bit cheaper.
- 1SXP is valuated correctly with a Price/Forward Earnings ratio of 14.11.
- 1SXP's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1SXP is cheaper than 86.36% of the companies in the same industry.
- 1SXP is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 25.96, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.74 | ||
| Fwd PE | 14.11 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1SXP indicates a somewhat cheap valuation: 1SXP is cheaper than 77.27% of the companies listed in the same industry.
- 1SXP's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 48.64 | ||
| EV/EBITDA | 9.34 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of 1SXP may justify a higher PE ratio.
- A more expensive valuation may be justified as 1SXP's earnings are expected to grow with 15.84% in the coming years.
PEG (NY)0.9
PEG (5Y)N/A
EPS Next 2Y16.45%
EPS Next 3Y15.84%
5. Dividend
5.1 Amount
- 1SXP has a Yearly Dividend Yield of 1.21%. Purely for dividend investing, there may be better candidates out there.
- 1SXP's Dividend Yield is rather good when compared to the industry average which is at 0.48. 1SXP pays more dividend than 86.36% of the companies in the same industry.
- 1SXP's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.21% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
- 16.40% of the earnings are spent on dividend by 1SXP. This is a low number and sustainable payout ratio.
DP16.4%
EPS Next 2Y16.45%
EPS Next 3Y15.84%
SCHOTT PHARMA AG& CO KGAA / 1SXP.MI FAQ
Can you provide the ChartMill fundamental rating for SCHOTT PHARMA AG& CO KGAA?
ChartMill assigns a fundamental rating of 6 / 10 to 1SXP.MI.
What is the valuation status for 1SXP stock?
ChartMill assigns a valuation rating of 5 / 10 to SCHOTT PHARMA AG& CO KGAA (1SXP.MI). This can be considered as Fairly Valued.
How profitable is SCHOTT PHARMA AG& CO KGAA (1SXP.MI) stock?
SCHOTT PHARMA AG& CO KGAA (1SXP.MI) has a profitability rating of 8 / 10.
Can you provide the financial health for 1SXP stock?
The financial health rating of SCHOTT PHARMA AG& CO KGAA (1SXP.MI) is 5 / 10.
What is the earnings growth outlook for SCHOTT PHARMA AG& CO KGAA?
The Earnings per Share (EPS) of SCHOTT PHARMA AG& CO KGAA (1SXP.MI) is expected to grow by 18.66% in the next year.